Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Albumins × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Hematologic Diseases 1

Interventions

Cyclophosphamide 18 Brentuximab Vedotin 18 fludarabine 14 Rituximab 11 Melphalan 10 Lenalidomide 10 Busulfan 10 fludarabine phosphate 9 Mycophenolic Acid 9 Dexamethasone 9 pirtobrutinib 7 Whole-Body Irradiation 7 Tacrolimus 7 Bortezomib 7 dacetuzumab 6 ruxolitinib 5 Imatinib Mesylate 5 Doxorubicin 5 Bone Marrow Transplantation 5 Azacitidine 5 ponatinib 4 Vincristine 4 Prednisone 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Blood Specimen Collection 4 nilotinib 3 lintuzumab 3 ibrutinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06095752 2025-10-02

Multiple Myeloma Prognostic Indices

Assiut University

Hematologic Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡